Clinical ResearchInterventional CardiologyValue of the SYNTAX Score for Risk Assessment in the All-Comers Population of the Randomized Multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial
Interventional Cardiology
Under an Elsevier user license
open archive
Key Words
biodegradable polymer
biolimus-eluting stent
major adverse cardiac event
prognostic value
sirolimus-eluting stent
target vessel revascularization
SYNTAX score
Abbreviations and Acronyms
CI
confidence interval
HR
hazard ratio
MACE
major adverse cardiac event(s)
MI
myocardial infarction
SXhigh
SYNTAX score >16
SXlow
SYNTAX score ≤8
SXmid
SYNTAX score >8 and ≤16
SXscore
SYNTAX score
TVR
target vessel revascularization
Cited by (0)
Dr. Eberli is currently working at Triemlispital, Zurich, Switzerland. Funding for this paper was received from Biosensors Europe SA, Switzerland. Dr. Linke is a consultant for Medtronic. Dr. Windecker receives lecture and consulting fees from Abbott, Boston Scientific, Biosensors, Cordis, and Medtronic. Dr. di Mario’s institution has received a research grant from Biosensors. Dr. Eberli is a consultant for the Cordis Company, and has received research grants from Biosensors, Medtronic, and Abbott Vascular.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.